Location History:
- Baltimore, MD (US) (2020)
- Elkridge, MD (US) (2021 - 2023)
Company Filing History:
3 out of 3,566 
2 out of 1,944 
1 out of 3,696 
Years Active: 2020-2025
Title: The Innovative Contributions of Todd Gould
Introduction
Todd Gould is a notable inventor based in Elkridge, MD (US). He has made significant contributions to the field of pharmacology, particularly in the synthesis of novel compounds. With a total of 4 patents to his name, his work has garnered attention for its potential applications in medicine.
Latest Patents
Gould's latest patents focus on the crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine. The disclosures provide methods for synthesizing free base forms of these compounds. In one embodiment, the synthesis of (2R,6R)-hydroxynorketamine (HNK) involves the preparation of (R)-norketamine through chiral resolution from racemic norketamine using L-pyroglutamic acid. Additionally, the disclosures include crystal forms of the corresponding (2R,6R)-hydroxynorketamine (HNK) and (2S,6S)-hydroxynorketamine hydrochloride salts.
Career Highlights
Throughout his career, Todd Gould has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University System of Maryland. His work in these institutions has contributed to advancements in the understanding and application of hydroxynorketamine compounds.
Collaborations
Gould has collaborated with notable colleagues such as Craig J Thomas and Carlos A Zarate. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Todd Gould's innovative work in the synthesis of hydroxynorketamine compounds highlights his significant contributions to pharmacology. His patents reflect a commitment to advancing medical science and improving therapeutic options.